These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8337976)

  • 1. [Immunological effect of recombinant interferon-gamma in renal cell carcinoma].
    Kawata N; Ono M; Endo M; Ichinose T; Hamada T; Hirano D; Fuse T; Takimoto Y
    Hinyokika Kiyo; 1993 Jun; 39(6):511-5. PubMed ID: 8337976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological effect of recombinant interferon-gamma on tumor infiltrating lymphocytes of renal cell carcinoma--relationship with clinical stage].
    Kawata N; Takimoto Y; Hirano D; Yamamoto T; Hirakata H; Yamanaka Y; Okada Y; Chino K; Sugimoto S; Igarashi T
    Hinyokika Kiyo; 1996 Jan; 42(1):1-4. PubMed ID: 8686575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
    Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
    Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
    Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
    Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
    Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
    Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological assessment after radical nephrectomy for renal cell carcinomas pre-treated with interferon-gamma].
    Onishi T; Machida T; Masuda F; Igarashi H
    Hinyokika Kiyo; 1991 Jul; 37(7):671-8. PubMed ID: 1927765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of nephrectomy and interferon administration on immunological parameters in patients with renal cell carcinoma].
    Arima K; Yanagawa M; Sugimura Y; Tochigi H; Kawamura J; Saitoh K; Yamazaki Y; Mori O; Oomoto Y; Nakagawa M
    Hinyokika Kiyo; 1994 Jun; 40(6):469-74. PubMed ID: 8073952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological study of interferon-gamma therapy for advanced renal cell carcinoma].
    Aoyagi T; Murai M; Kimura F; Sawamura M; Asano T; Odajima K; Nagakura K; Nakamura H
    Hinyokika Kiyo; 1992 Dec; 38(12):1357-60. PubMed ID: 1288223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
    Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
    Cózar JM; Canton J; Tallada M; Concha A; Cabrera T; Garrido F; Ruiz-Cabello Osuna F
    Cancer Immunol Immunother; 2005 Sep; 54(9):858-66. PubMed ID: 15887015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
    Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the activating effects of recombinant human interleukin 2 and interferon-gamma on cell-mediated cytotoxicity against renal cell carcinoma in vitro].
    Marumo K; Ueno M; Baba S; Muraki J; Deguchi N; Tazaki H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1825-9. PubMed ID: 3109327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
    Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF
    Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the immunological effects of interleukin-2 in patients with bladder cancer and renal cell carcinoma.
    Hermann GG
    APMIS Suppl; 1993; 35():1-26. PubMed ID: 8251200
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic interferon gamma application in patients with renal cell carcinoma.
    Grups JW; Frohmüller HG
    Prog Clin Biol Res; 1990; 350():257-62. PubMed ID: 2117285
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effects and immunological changes in interferon therapy for advanced renal cell carcinoma].
    Kudo T; Souma H; Kudo S; Kogawa T; Suzuki T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):40-6. PubMed ID: 2109026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.